ascopubs.org

A novel single domain antibody (sdAb) SBT-100 to target intracellular STAT3 to affect growth and regression of human triple negative breast cancer (TNBC) cells.

Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Prelinical investigation with the anti-p53 drug, APR-246. This is an ASCO Meeting Abstract from the 2016 ASCO ...
Yahoo Finance

(SDAB) Stock Price, News, Quote & History - Yahoo Finance

Find the latest (SDAB) stock quote, history, news and other vital information to help you with your stock trading and investing.
ascopubs.org

A novel single domain antibody (sdAb) SBT-100 targeting intracellular STAT3 to inhibit major subtypes of human breast cancer.

A Phase I/Ib study of MEK162 (binimetinib), a MEK inhibitor, in combination with carboplatin and pemetrexed in patients with non-squamous NSCLC. This is an ASCO Meeting Abstract from the 2016 ASCO ...